Skip left side navigation and go to content Skip left side navigation and go to content
center for human immunology and inflammation logo

CHI Graphic Banner

Archived Super NERD Series

The Novel Experimental Research Developments (NERD) series is an Educational Activity of the (upcoming) Federation of Clinical Societies (FOCIS) Center for Excellence representing a join effort between the Infectious Disease and Immunogenetic Section (IDIS), Department of Transfusion Medicine and the Center for Human Immunology (CHI). Its scope is to reach the intra-mural community with primarily focus on the CHI membership. The NERD series favors on the presentation of novel technical and methodological advances relevant to basic and/or clinical research that would not typically fit the broader purposes of most scientific lecture series held at the NIH. The NERD series is taking advantage of the outstanding areas of expertise present in the intra-mural community and the organizers are happy to consider any suggestions/ recommendation for topics from any member of the NIH community; in addition, the NERD series encourages presentations from Academia, FDA or Commercial Sector from other National or International Institution.

The Super NERD lectures are part of the NERD series; they share the same purposes and venues but, because of the perceived broader interest of the topic discussed, are more extensively advertised.

The NERD series is organized by Dr. Marianna Sabatino (Director of NERDs) and it is under the supervision of the "CHI working group on standardization of tissue/sample collection and storage" chaired by Bibi Bielekova, Francesco M Marincola and Giorgio Trinchieri. Further questions regarding the series and suggestions for topics/participation should be e-mailed to:

Both NERD and Super NERD series are held (unless otherwise stated) on Fridays at 3:00 PM in the Conference Room of the Department of Transfusion Medicine (1C726, Bldg 10).


2012 Lectures


Date

Speaker

Affiliation

Subject

Friday, October 19, 2012

Dr. Thomas Kleen, Executive VP Immune Monitoring

Epiontis GmbH, Germany

"Novel Epigenetic Immune Cell Markers Enable Standardized Immune Monitoring from Frozen Whole Blood or Tissue during Clinical Trials"

Friday, July 13rd

MaryBeth Panagos

GENEWIZ, INC.

"Simbiot®: A new tool for analyzing Next Generation Sequencing Data"

Friday, June 22nd

Dr Pia Riestra

Institute of Applied Molecular Medicine (IMMA), CEU-San Pablo University School of Medicine and Hospital of Madrid Scientific Foundation, Spain

"Relationship between obesity at the pubertal age with hormonal and genetic factors related to energy homeostasis"

Friday, June 1st, 2012

Meaghan Parker Key Account Manager, East Coast US

Biomatters, Inc.

"DNA Sequence Analysis Software for Biologists"


2011 Lectures


Date

Speaker

Affiliation

Subject

November 18, 2011

Ming Guo

Stanford University

"Gene Disease Association and the Meridian Chart - A Novel Way of Discovering Diseases Relationships."

October 21, 2011

Dr. Ina K Dahlsveen, Ph.D.

Exiqon Inc.

"Discovery and validation of microRNA based diagnostic biomarkers for cancer."

October 12, 2011

Prof. Ruggero Cadossi, President

IGEA, Italy

"Electrochemotherapy for tumour treatment: results and perspectives."

September 16, 2011

Tony Scheaffer

Linguamatics external link

Discovering insights by unlocking scientific information from unstructured text

September 9, 2011

Rita Okereke

BIOSCALEexternal link

Development of Assays for Rapid and Sensitive Analysis of Protein Biomarkers in Complex Biological Matrices using BioScale's Immunoassay-based Acoustic Membrane MicroParticle Technology

August 5, 3-4PM, 2011

Troels Scheel, PhD

Copenhagen Hepatitis C Program (CO-HEP), Copenhagen University Hospital, Hvidovre, and University of Copenhagen, Denmark -Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY

"Studies of antivirals in hepatitis C virus cell culture systems using high-throughput counting of infected cells."

July 29, 3PM, 2011

Meredith Potts, Executive Director

Flagstaff Internal Relief Effort (FIRE), Flagstaff, Arizona. Phone: 928-600-6361, meredithpotts@gmail.com

"FIRE: Public Health Programs in Mongolia."

Friday, June 24th, 2011

Barbara Seliger

Martin-Luther-Universität Halle-Wittenberg

Novel insights into the HLA-G- class I alterations in tumor

May 20, 2011

Silvia Selleri, Ph.D.

CHU Sainte-Justine, Montreal, QC, Canada

MSC as immunomodulatory tool for GVHD treatment: In vitro studies

March 25, 2011

Charles Ginsburg

Sword Diagnostics

Optimization of HRPO-based ELISA using Raman type signalling reagents

March 18, 2011

Thomas E Ichim

Medistem, Inc.

"Clinical Development of Menstrual Blood Stem Cells for Critical Limb Ischemia"

Jan. 28, 2011

Dr. Christian Gabriel, Primar Dr Med (M.D.)

Blood Center, Linz, Austria

Next Generation Sequencing and HLA



2010 Lectures


Date

Speaker

Affiliation

Subject

Nov. 12

Dr. Yusibov Vidadi

Fraunhofer CMB

High performance plant-based technology for protein production

Oct. 19

Martin Scott

NHGRI

High-Throughput RNAi Screening at the NIH

Oct. 9

Dragan Maric

NINDS

 

Aug. 20

Grace Johnston

Fluidigm Corporation

Single Cell Gene Expression Analysis Using the Fluidigm BioMark™ Platform

July 30

Anis H. Khimani
Tiziana Di Pucchio

SeraCare Life Sciences

Cryopreserved Peripheral BloodMononuclear Cells (PBMCs) in Cell Based Applications in Immune Response Monitoring

July 16

Samuel C. Silverstein, M.D.

Columbia University

A Critical Concentration of Cytolytically Active Antigen-specific CD8+T-cells Is Required to Control Growth of Cognate-antigen Expressing Melanoma Cells in vitro and in vivo.

April 9

Heath Balcer

Life Technologies

Rapid Biomarker Discovery using protein arrays

March 13

Stefano Bertuzzi

NIH/NINDS

Behind medicine: science and policy



2009 Lectures

Date

Speaker

Affiliation

Subject

Dec. 4

Anthon Yuryev

Ariadne Genomics

Using published biological knowledge to advance the mechanistic understanding of a disease (Glioblastoma), identify novel targets, and evaluate possible combinatorial therapies

Dec. 1

Leslie G. Biesecker

NIH/NHGRI

The ClinSeq project: a pilot project for clinical genomics

Nov. 6

Anatoli Malyguine

NIH/NCI

CLIA-certified and upcoming new cellular assays for T cell immune monitoring in response to vaccination

Oct. 16

Dr. Harvey J. Alter

Chief, Infectious Disease Section, NIH

A Backward Look into the Future: Hepatitis Then and Now

Oct. 9

Dr. Rachele Karon

Life Technologies

Next Generation siRNA Technology: Improved Efficacy, Potency, and Specificity for Cleaner RNAi Results

Oct. 2

Jia-Hai Lee

World Patent and Trademark Law Group

Target Validation: Cyclic GMP-dependent protein kinase is a potential drug target of HIV-1

Sept. 25

Frank Nice

NIH/CC/PHAR

Haiti Medical Missions: Lessons Learned

Sept. 11

Barbara Seliger

Institute of Medical Immunology, Halle (Saale), Germany

Novel insights into the molecular mechanism of MHC class I antigen processing and presentation components in tumors

Aug. 28

Ariya Bira
Richard J. Mcguire

NIH/NIA/IRP
Ocimum Biosolutions

Medical Challenges and Scientific Opportunities in Mongolia
LIMS as Infrastructure for Translational Research Transforming Clinical, Clinical Diagnostics, and Transfusion Medicine Research into a single network for Immugonetics Studies

Aug. 21

Dr. David Sloan

Mesoscale

Enabling Clinical Research through Performance Biomarker Detection

July 31

Joost J. Oppenheim

NCI Frederick

Alarmins mobilize and activate host immune responses

July 10

Eyal Talor

CEL-SCI Corporation

Multikine: Cancer Immunotherapy (How to make immunotherapy for cancer work)

June 12

Janet Siebert

Cytoanalytics

Exhaust Your Data Before It Exhausts You

May 15

Laurie Phillips

GenoLogics - Informatics Solutions for Life Sciences

Data management for a gene expression & SNP genotyping lab

May 1

Dr. David Stroncek
Dr. Susan Leitman

NIH/DTM/CPS
NIH/DTM

Proteins and Potency
Effect of repeated aphreseses on circulating immune cells

April 24

Dr. Allison Hubel

University of Minnesota

Cryopreservation of cell therapies and tissues

April 9

Heath Balcer

Life Technologies

Rapid Biomarker Discovery using protein arrays



Last Updated December 2012




Skip footer links and go to content

This site is hosted by the NHLBI